Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Immunotherapy cancer vaccine in phase II

Feb. 20, 1997

Encouraging results obtained for immunotoxin in Hodgkin's lymphoma

Feb. 17, 1997

Labeled SMART antibody shows promise for AML treatment

Feb. 17, 1997

Maxim's lead product approaches pivotal trials

Feb. 12, 1997

Genzyme Transgenics reports advances in transgenic production of MAbs

Feb. 11, 1997

Il Yang develops antitumor/immunostimulating proteoglycan

Feb. 7, 1997

AltaRex's lead product given orphan drug status

Jan. 17, 1997

CPMP approves unified labeling for Intron A

Jan. 17, 1997

Immunotherapeutic vaccine for CML reported in patent literature

Jan. 17, 1997

Roche/Genentech marketing agreement for Roferon-A

Jan. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...